«These findings are important because it is currently hard to distinguish early which patients will
benefit from radiation therapy following radical prostatectomy and which will receive no benefit,» says Bell.
Many metabolic issues exist for patients with cancer, especially those with normal eating barriers from their cancer, side
effects from radiation therapy and chemotherapy, digestive issues from their cancer, and those on novel treatments or clinical trials.